← All diseases Blood and bone marrow

Myelofibrosis

Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence

Search Period All yearsLast 12 monthsLast 5 years Topic All topicsGeneralNutrition and dietAlternative treatment methods Type of research Any type of researchOnly the most rigorous evidence (43)Treatment guideline (6)Meta-analysis (5)Phase 3 study (19)Randomized trial (9)Systematic review (4)Clinical Trial (599)Review article (228)Early study (phase 1 or 2) (41)Case reports (176)Laboratory or animal research (16)Commentary or editorial (73)Retracted publication (1) Studies currently recruiting participants only (37)

Filter

Publications and studies (1631)

• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. A megakaryocyte in a peripheral blood smear. (2019/12/01) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice. (2019/12/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Transcriptional alteration of DNA repair genes in Philadelphia chromosome negative myeloproliferative neoplasms. (2019/12/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Development of myelofibrosis and acute monocytic leukemia in a patient with hereditary spherocytosis: A case report. (2019/12/01) ♡
• EBV reactivation mimicking a lymphoproliferative disorder associated with ruxolitinib therapy for myelofibrosis. (2019/12/01) ♡
• Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma. (2019/11/30) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. From Budd-Chiari syndrome to acquired von Willebrand syndrome: thrombosis and bleeding complications in the myeloproliferative neoplasms. (2019/11/28) ♡
• The pan-PIM inhibitor INCB053914 displays potent synergy in combination with ruxolitinib in models of MPN. (2019/11/26) ♡
• Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms. (2019/11/26) ♡
• Invariant patterns of clonal succession determine specific clinical features of myelodysplastic syndromes. (2019/11/26) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Cementless bipolar hemiarthroplasty in a patient with PMF: a case report. (2019/11/15) ♡
• Second primary malignancies in ruxolitinib-treated myelofibrosis: real-world evidence from 219 consecutive patients. (2019/11/12) ♡
• Metabolic Effects of JAK1/2 Inhibition in Patients with Myeloproliferative Neoplasms. (2019/11/12) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Mechanisms Underlying the Anti-inflammatory and Immunosuppressive Activity of Ruxolitinib. (2019/11/07) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. JAK-inhibitors in dermatology: current evidence and future applications. (2019/11/01) ♡
• Vitamin B6 deficiency is prevalent in primary and secondary myelofibrosis patients. (2019/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Myelofibrosis associated with systemic lupus erythematosus successfully treated with rituximab. (2019/11/01) ♡
• Myelofibrosis in Patients of Chronic Myeloid Leukemia in Chronic Phase at Presentation. (2019/11/01) ♡
• Clinical trialiResearch in patients, without randomization between groups. Useful, but less certain than a randomized trial. Shared and Tissue-Specific Expression Signatures between Bone Marrow from Primary Myelofibrosis and Essential Thrombocythemia. (2019/11/01) ♡
• The Temporal Sequence and the Differences in Somatic Mutation Acquisition Determines Clinical Behaviors of JAK2-Positive Myeloproliferative Neoplasms. (2019/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. [CURRENT CRITERIA FOR THE DIAGNOSIS OF MYELOPROLIFERATIVE NEOPLASMS - WHAT IS IMPORTANT TO KNOW?]. (2019/11/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Splenic Marginal Zone Lymphoma with Prominent Myelofibrosis Mimicking Triple-Negative Primary Myelofibrosis. (2019/11/01) ♡
• Vascular Diseases In Patients With Chronic Myeloproliferative Neoplasms - Impact Of Comorbidity. (2019/11/01) ♡
• Pachydermoperiostosis Associated with Myelofibrosis: A Rare Case Report. (2019/11/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis. (2019/11/01) ♡
• Unclassifiable non-CML classical myeloproliferative diseases with microcytosis: findings indicating diagnosis of polycythemia vera masked by iron deficiency. (2019/10/24) ♡
• Digital PCR - Methods and Protocols. (2019/10/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Polycythemia Vera-Associated Complications: Pathogenesis, Clinical Manifestations, And Effects On Outcomes. (2019/10/18) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Experimental Modeling of Myeloproliferative Neoplasms. (2019/10/15) ♡
• Laboratory or animal researchiNo research in humans yet. Promising in a test tube or in mice unfortunately means nothing for patients. A conditional inducible JAK2V617F transgenic mouse model reveals myeloproliferative disease that is reversible upon switching off transgene expression. (2019/10/10) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Autoimmune panmyelosis with myelofibrosis. (2019/10/10) ♡
• Myeloid sarcoma manifesting as generalized lymphadenopathy in a patient with myelofibrosis. (2019/10/04) ♡
• Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Association of Treatments for Myeloproliferative Neoplasms During Pregnancy With Birth Rates and Maternal Outcomes: A Systematic Review and Meta-analysis. (2019/10/02) ♡
• Home enteral nutrition may prevent myelosuppression of patients with nasopharyngeal carcinoma treated by concurrent chemoradiotherapy. (2019/10/01) ♡
• Pulmonary hypertension in patients with myeloproliferative neoplasms: A large cohort of 183 patients. (2019/10/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fedratinib: First Approval. (2019/10/01) ♡
• Gene Polymorphism of Xenobiotic Biotransformation Enzymes in Patients with Classical Ph-Negative Myeloproliferative Neoplasms. (2019/10/01) ♡
• Primary myelofibrosis marrow-derived CD14+/CD34- monocytes induce myelofibrosis-like phenotype in immunodeficient mice and give rise to megakaryocytes. (2019/09/30) ♡
• Conjugated polymers optically regulate the fate of endothelial colony-forming cells. (2019/09/27) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Standard care and investigational drugs in the treatment of myelofibrosis. (2019/09/26) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Novel strategies for the treatment of myelofibrosis driven by recent advances in understanding the role of the microenvironment in its etiology. (2019/09/19) ♡
• A rare cause of acute coronary syndromes in young adults - myeloproliferative neoplasms: A case series. (2019/09/01) ♡
• Treatment outcome of Philadelphia chromosome negative myeloproliferative neoplasms: experience of a single developing country's hematology-oncology centre. (2019/09/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Recommendations for the use of pegylated interferon-α in the treatment of classical myeloproliferative neoplasms. (2019/08/01) ♡
• Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Fatal case of TAFRO syndrome associated with over-immunosuppression: a case report and review of the literature. (2019/08/01) ♡
• Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Hodgkin lymphoma with co-existing extramedullary haematopoiesis in a Thalasaemia Major patient: Killing two birds with one stone using PET-CT. (2019/07/01) ♡
• AXL Inhibition Extinguishes Primitive JAK2 Mutated Myeloproliferative Neoplasm Progenitor Cells. (2019/06/04) ♡
• Circulating megakaryocyte and platelet microvesicles correlate with response to ruxolitinib and distinct disease severity in patients with myelofibrosis. (2019/06/01) ♡
• Italian expert panel consensus statement on the optimal use of PD-1 blockade therapy in classical Hodgkin lymphoma. (2019/05/01) ♡
• Commentary or editorialiAn expert's opinion or commentary, not new research. Mutations and prognosis in myeloproliferative neoplasms. (2019/05/01) ♡

↑ Back to top

codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.